PROOFWAKE FIELD GUIDE
How to read a paused-drug brief
A finished trial, a development pause, and a drug that is available to license are three different things. Don’t let one stand in for another.
Get the blank worksheet What’s a comparator?
1. What was actually studied?
Check the condition, who took part, what was measured, and what the study compared. In the EQ101 example, the study involved people with alopecia areata and had no comparison group. The reported changes describe that group. They don’t isolate how much change was due to the drug. Study record · Posted results
2. What was paused, and who said so?
A registry status describes the study, not the drug program. Look for a dated company or regulatory disclosure and say exactly what it establishes. Read the Equillium annual filing separately from the study record.
3. Who can discuss rights or share the data?
A sponsor’s name is a starting point, not proof of who can sign a deal or provide the complete study report today. Label each answer separately. If you can’t verify it, say so.
4. What would change the call?
EQ101 is a Hold on this public-record first pass. The comparison gap limits the conclusion, and current rights and data access are unverified. The next question: who can confirm the program’s status and show the full human study report?
This is education about reading public records, not medical or investment advice, or an assessment of safety or effectiveness.